|Mr. Wern-Yi Goh||CEO & Director||240k||N/A||1967|
|Dr. Morris S. Berrie||Pres & Member of Advisory Board||N/A||N/A||1965|
|Mr. Adam O'Keeffe||Ad Interim Chief Financial Officer||N/A||N/A||N/A|
|Mr. Chunhyok Chong||Head of Devel.||N/A||N/A||1973|
|Mr. Windiaprana Ramelan||Head of Operations Asia||N/A||N/A||1970|
|Mikko Tirronen||Head of Operations Europe||N/A||N/A||N/A|
|Mr. Richard Lingard||Sr. VP of Commercialisation||N/A||N/A||N/A|
|Mr. Kiki Rizki||Gen. Mang. of Indonesia||N/A||N/A||N/A|
Achiko AG, together with its subsidiaries, engages in the healthtech business in Indonesia, Singapore, and Hong Kong. The company develops Teman Sehat, a mobile app with a digital passporting service that manages the booking, payment, and diagnostic testing for Covid-19; and AptameX, a saliva-based diagnostic test for the detection of Covid-19. It also offers secure payment solutions for game publishers and application developers to accept various payment methods for digital contents and goods under the Mimopay brand, as well as develops game software. The company was incorporated in 2018 and is headquartered in ZÃ¼rich, Switzerland.
Achiko AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.